Read on Twitter
So @pfizer INTERIM ANALYSIS of their mRNA vaccine looks promising. Article indicates 94 people in study have been infected - breakdown of placebo/dose@not@disclosed by#ut “90% effective” is better than anticipated. Good RCT demo. https://www.wsj.com/articles/covid-19-vaccine-from-pfizer-and-biontech-works-better-than-expected-11604922300?reflink=share_mobilewebshare
This is a mRNA-based vaccine, expressing spike protein.
Other vaccines are at a similar market stage in clinical trials, and next month or two should see a lot more data from interim and final read outs.
Other vaccines are at a similar market stage in clinical trials, and next month or two should see a lot more data from interim and final read outs.
Importantly, there are no serious safety issues!!! Study participants will be monitored for a few more months as part of trial.
Another good day for science.
Sorry for the typos. Was too excited.
Another good day for science.
Sorry for the typos. Was too excited.
164 people need to be infected for trial to close out.
Meantime, manufacturing is UNDERWAY , so if approved they’ll be ready to roll (with a modest 50M doses) and over 1 Billion in 2021.
Meantime, manufacturing is UNDERWAY , so if approved they’ll be ready to roll (with a modest 50M doses) and over 1 Billion in 2021.
